Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMWL
AMWL logo

AMWL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
8.000
Open
7.750
VWAP
7.82
Vol
119.59K
Mkt Cap
133.17M
Low
7.480
Amount
934.80K
EV/EBITDA(TTM)
--
Total Shares
16.71M
EV
-36.93M
EV/OCF(TTM)
--
P/S(TTM)
0.53
American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.
Show More

Events Timeline

(ET)
2026-02-12
16:30:00
Sees Q1 Adjusted EBITDA in Range of ($7M)-($5M)
select
2026-02-12
16:30:00
Amwell Reports Q4 Revenue of $55.3M, Exceeds Expectations
select
2026-02-12
16:30:00
Company Sees FY26 AMG Visits Between 1.32M-1.37M
select

News

seekingalpha
9.5
05-06seekingalpha
PinnedAmerican Well Q1 2026 Earnings Call Insights Highlighting Growth and Profitability Path
  • Strong Financial Performance: American Well reported total revenue of $54.9 million in Q1 2026, with a gross profit of $28 million and a gross margin of 51%, reflecting robust visit volumes in urgent care and clinical programs while maintaining cost discipline, thereby enhancing its competitive position in the market.
  • Improved Adjusted EBITDA Outlook: The company now expects its full-year adjusted EBITDA loss for 2026 to narrow to between $16 million and $12 million, down from the previous forecast of $24 million to $18 million, indicating increased management confidence in profitability trajectory.
  • Healthy Cash Flow Position: As of the end of Q1, American Well had $179 million in cash and investments with no debt, with management outlining a clear path to cash flow breakeven by Q4 2026, which bolsters investor confidence in the company's financial stability.
  • Positive Forward Guidance: The company anticipates Q2 2026 revenue in the range of $48 million to $52 million, suggesting strong future growth potential driven by ongoing customer demand and market expansion, particularly in telehealth and behavioral health sectors.
NASDAQ.COM
9.5
04-16NASDAQ.COM
American Well Corporation Shares Surge 13.3% Amid Strong Q4 Outlook
  • Significant Price Surge: American Well Corporation (AMWL) shares rallied 13.3% in the last trading session to close at $6.24, with notable trading volume indicating strong investor optimism regarding the company's future performance.
  • Strong Financial Performance: The company reported fourth-quarter sales of $55.3 million, surpassing the Zacks Consensus Estimate by 5.3%, highlighting its robust growth potential in the digital healthcare sector, which may attract more investor interest.
  • Future Expectations: Although a quarterly loss of $0.77 per share is anticipated, reflecting a year-over-year increase of 55.5%, revenues are expected to decline by 24.8% to $50.25 million, indicating cautious market sentiment regarding the company's future profitability.
  • Market Trend Monitoring: Despite the consensus EPS estimate remaining unchanged over the past 30 days, the stock's upward movement may be linked to growing investor enthusiasm for AI-driven digital healthcare platforms, making AMWL's future performance worth monitoring.
Fool
2.0
03-12Fool
Hims & Hers Health Shares Drop 7.75% Amid Profit-Taking
  • Stock Fluctuation: Hims & Hers Health closed at $23.84 on Thursday, down 7.88%, primarily due to traders taking profits after a strong rally following its partnership with Novo Nordisk, indicating market concerns over the execution of its branded obesity drugs.
  • Surge in Trading Volume: The trading volume reached 68 million shares, about 126% above the three-month average of 30 million shares, reflecting heightened market interest in the company's dynamics, and despite the price drop, investors remain focused on its future performance.
  • Long-Term Performance Analysis: Despite Thursday's decline, Hims & Hers saw a 50% increase in stock price over the last five trading days, driven by the Novo Nordisk partnership, impressive earnings report, and analyst upgrades, showcasing a strong short-term rebound.
  • Legal Risk Warning: Investors should be aware of the legal risks associated with the company's products potentially falling into a gray area around patent protections, particularly as they monitor potential litigation and partnership agreements that could impact the company's long-term growth prospects.
Newsfilter
5.0
02-18Newsfilter
Amwell Grants 61,559 RSUs to New Employee as Inducement
  • Employee Inducement Plan: On February 18, 2026, Amwell granted 61,559 restricted stock units (RSUs) to a new employee as a significant inducement for employment, demonstrating the company's commitment to attracting and retaining talent.
  • Vesting Schedule: The RSUs will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal pro-rata increments every three months over three years, ensuring employee stability and long-term commitment during this period.
  • Compliance Assurance: This grant was approved by Amwell's Compensation Committee and made in reliance on the employment inducement exemption under NYSE's Listed Company Manual Rule 303A.08, ensuring the company operates within compliance frameworks.
  • Platform Advantage: Amwell offers a comprehensive technology-enabled healthcare platform aimed at providing patients with more convenient, affordable, and effective care, and as demand for online healthcare increases, the company's competitive position and influence in the market continue to grow.
seekingalpha
9.5
02-13seekingalpha
American Well Corporation Q4 2025 Earnings Call Insights
  • Strategic Transformation: American Well Corporation is undergoing a significant transformation in 2025, focusing on delivering the best tech platform in the market by divesting non-core activities and restructuring the company, which has dramatically reduced costs and set the stage for achieving cash flow breakeven in 2026.
  • Revenue Structure Optimization: The total revenue for 2025 was $249.3 million, with subscription revenue comprising 53% of total revenue, up from 45% in 2024, indicating strategic progress towards high-quality, sustainable revenue despite a 22.1% year-over-year decline in overall revenue.
  • Future Outlook: The company expects revenue in the range of $195 million to $205 million for 2026, with AMG visits projected between 1.32 million and 1.37 million, and adjusted EBITDA losses expected to decrease to between $24 million and $18 million, reflecting management's increased confidence in future cash flow.
  • Risks and Challenges: Management identified ongoing risks such as continued churn and the need to renew the DHA contract, although proactive measures in maintaining high renewal rates and transitioning to a single platform are being implemented to address challenges posed by emerging AI competitors.
seekingalpha
9.5
02-12seekingalpha
American Well Releases 2026 Financial Guidance with Q4 Results
  • Earnings Beat: American Well's Q4 GAAP EPS of -$1.52 exceeded expectations by $0.26, despite a revenue drop of 22.1% year-over-year to $55.31 million, which still beat estimates by $2.6 million, showcasing the company's resilience in challenging conditions.
  • 2026 Financial Outlook: The company projects 2026 revenue between $195 million and $205 million, with AMG visits expected between 1.32 million and 1.37 million, and adjusted EBITDA ranging from -$24 million to -$18 million, reflecting cautious optimism for future growth.
  • Q1 2026 Guidance: American Well anticipates Q1 2026 revenue between $48 million and $53 million, with adjusted EBITDA projected between -$7 million and -$5 million, indicating ongoing short-term challenges but potential for gradual improvement.
  • Positive Market Reaction: Despite the overall revenue decline, the market reacted positively to the company's earnings beat and future guidance, which may boost investor confidence and improve stock performance.
Wall Street analysts forecast AMWL stock price to rise
4 Analyst Rating
Wall Street analysts forecast AMWL stock price to rise
0 Buy
4 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 0.000
sliders
Low
6.00
Averages
6.00
High
6.00
TD Cowen
Charles Rhyee
Hold
maintain
$5 -> $8
AI Analysis
2026-05-06
New
Reason
TD Cowen
Charles Rhyee
Price Target
$5 -> $8
AI Analysis
2026-05-06
New
maintain
Hold
Reason
TD Cowen analyst Charles Rhyee raised the firm's price target on Amwell to $8 from $5 and keeps a Hold rating on the shares. The firm said the company beat on both Subscription revenue and Visits revenue and the company raised 2026 EBITDA guidance and set 2Q EBITDA guide above conensus.
Morgan Stanley
Equal Weight
maintain
$6
2026-05-06
New
Reason
Morgan Stanley
Price Target
$6
2026-05-06
New
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Amwell to $6.50 from $6 and keeps an Equal Weight rating on the shares. Revenue upside in the quarter and tighter cost controls "mark a solid start to the year, admittedly against low investor expectations," the analyst says in a post-earnings note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AMWL
Unlock Now

Valuation Metrics

The current forward P/E ratio for American Well Corp (AMWL.N) is 0.00, compared to its 5-year average forward P/E of -10.16. For a more detailed relative valuation and DCF analysis to assess American Well Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-10.16
Current PE
0.00
Overvalued PE
14.39
Undervalued PE
-34.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.17
Current EV/EBITDA
1.78
Overvalued EV/EBITDA
2.85
Undervalued EV/EBITDA
-5.18

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.55
Current PS
0.57
Overvalued PS
5.34
Undervalued PS
-0.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

low float medical tech stock
Intellectia · 68 candidates
Market Cap: 50.00M - 5.00BSector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchRegion: USPrice: $1.00 - $50.00Beta: ModerateRisk, HighRisk, LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000Floating Shares: <= 20,000,000
Ticker
Name
Market Cap$
top bottom
XLO logo
XLO
Xilio Therapeutics Inc
50.19M
LPCN logo
LPCN
Lipocine Inc
54.02M
LFVN logo
LFVN
LifeVantage Corp
54.88M
CLNN logo
CLNN
Clene Inc
63.49M
OM logo
OM
Outset Medical Inc
64.46M
ACET logo
ACET
Adicet Bio Inc
64.58M
I said one stock
Intellectia · 328 candidates
Market Cap: 50.00M - 2.00BRegion: USPrice: $0.50 - $20.00Market Cap Category: small, microBeta: HighRiskList Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 55Weekly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
OPRT logo
OPRT
Oportun Financial Corp
189.57M
ALTO logo
ALTO
Alto Ingredients Inc
360.26M
CHPT logo
CHPT
ChargePoint Holdings Inc
128.16M
ZIP logo
ZIP
Ziprecruiter Inc
238.89M
PLG logo
PLG
Platinum Group Metals Ltd
240.64M
PACK logo
PACK
Ranpak Holdings Corp
290.59M
best trades for daytrading today
Intellectia · 11 candidates
Volume: 0 - 10,000,000,000Price Change Pct: $1.50 - $100.00Relative Vol: 1.50 - 100List Exchange: XNYSSupport Resistance Relationship: PriceBreakResistance, PriceFallBelowSupportThree Min Rate Of Change: 0.3% - 100.0%
Ticker
Name
Market Cap$
top bottom
LMND logo
LMND
Lemonade Inc
3.94B
EXK logo
EXK
Endeavour Silver Corp
3.89B
AMWL logo
AMWL
American Well Corp
89.88M
HL logo
HL
Hecla Mining Co
15.63B
PSQH logo
PSQH
PSQ Holdings Inc
32.85M
FDS logo
FDS
Factset Research Systems Inc
7.67B
What stocks are about to reverse trend
Intellectia · 14 candidates
Price: $3.00 - $100.00Moving Average Relationship: PriceCrossAboveMA20Month Price Change Pct: >= $0.00Support Resistance Relationship: PriceBreakResistanceMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
MLEC logo
MLEC
Moolec Science SA
6.27M
ATOM logo
ATOM
Atomera Inc
126.83M
FGL logo
FGL
Founder Group Ltd
7.47M
CRSR logo
CRSR
Corsair Gaming Inc
723.65M
AMWL logo
AMWL
American Well Corp
89.38M
LGCY logo
LGCY
Legacy Education Inc
145.68M
inom den amerikanska marknaden
Intellectia · 15 candidates
Market Cap: <= 1.50BPrice: <= $25.00Beta: HighRiskRsi 14: <= 45Month Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
SG logo
SG
Sweetgreen Inc
820.33M
NVX logo
NVX
NOVONIX Ltd
222.62M
LFMD logo
LFMD
LifeMD Inc
170.40M
TMCI logo
TMCI
Treace Medical Concepts Inc
166.30M
HFFG logo
HFFG
Hf Foods Group Inc
116.17M
PYXS logo
PYXS
Pyxis Oncology Inc
103.36M

Whales Holding AMWL

S
Senvest Management, LLC
Holding
AMWL
+6.79%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is American Well Corp (AMWL) stock price today?

The current price of AMWL is 7.97 USD — it has increased 2.84

What is American Well Corp (AMWL)'s business?

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

What is the price predicton of AMWL Stock?

Wall Street analysts forecast AMWL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMWL is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is American Well Corp (AMWL)'s revenue for the last quarter?

American Well Corp revenue for the last quarter amounts to 54.88M USD, decreased -17.88

What is American Well Corp (AMWL)'s earnings per share (EPS) for the last quarter?

American Well Corp. EPS for the last quarter amounts to -0.66 USD, decreased -44.54

How many employees does American Well Corp (AMWL). have?

American Well Corp (AMWL) has 562 emplpoyees as of May 09 2026.

What is American Well Corp (AMWL) market cap?

Today AMWL has the market capitalization of 133.17M USD.